Financials & SEC Filings | Xeris Biopharma Holdings, Inc.

Proxy Statements

Filing date	Description	Form	View
Feb 16, 2021	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001104659-21-023988.pdf 0001104659-21-023988.rtf 0001104659-21-023988.xls
Feb 16, 2021	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001398344-21-003553.pdf 0001398344-21-003553.rtf 0001398344-21-003553.xls
Feb 12, 2021	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001193805-21-000202.pdf 0001193805-21-000202.rtf 0001193805-21-000202.xls
Feb 11, 2021	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000902664-21-001172.pdf 0000902664-21-001172.rtf 0000902664-21-001172.xls
Feb 01, 2021	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000834237-21-005690.pdf 0000834237-21-005690.rtf
Feb 01, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001346302-21-000006.pdf 0001346302-21-000006.rtf 0001346302-21-000006.xls
Feb 01, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001346302-21-000008.pdf 0001346302-21-000008.rtf 0001346302-21-000008.xls
Feb 01, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001346302-21-000010.pdf 0001346302-21-000010.rtf 0001346302-21-000010.xls
Feb 01, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001346302-21-000012.pdf 0001346302-21-000012.rtf 0001346302-21-000012.xls
Feb 01, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001346302-21-000014.pdf 0001346302-21-000014.rtf 0001346302-21-000014.xls

Data provided by Kaleidoscope.